G. Moser, S. Trägner, E. Gajowniczek, A. Mikulits, M. Michalski et al., Long-Term Success of GUT-Directed Group Hypnosis for Patients With Refractory Irritable Bowel Syndrome: A Randomized Controlled Trial, The American Journal of Gastroenterology, vol.107, issue.4, pp.602-609, 2013.
DOI : 10.1038/ajg.2013.19

B. Bonaz, J. Sabate, . Gf, W. Thompson, W. Chey et al., Functional bowel disorders, Gastroenterol Clin Biol. févr Gastroenterology. avr, vol.33130, issue.5, pp.1480-1491, 2006.

D. Drossman, The Functional Gastrointestinal Disorders and the Rome III Process, Gastroenterology, vol.130, issue.5
DOI : 10.1053/j.gastro.2006.03.008

M. Dapoigny, J. Bellanger, B. Bonaz, S. Bruley-des-varannes, L. Bueno et al., Irritable bowel syndrome in France, European Journal of Gastroenterology & Hepatology, vol.16, issue.10, pp.995-1001, 2004.
DOI : 10.1097/00042737-200410000-00008

M. Dapoigny, Syndrome de l???intestin irritable : ??pid??miologie/poids ??conomique, Gastroent??rologie Clinique et Biologique, vol.33
DOI : 10.1016/S0399-8320(09)71519-2

M. Dapoigny, S. Varannes, and . Des, Syndrome de l'intestin irritable : un poids lourd de la gastroentérologie. Hépato-Gastro, pp.175-177, 2006.

R. Levy, K. Olden, B. Naliboff, L. Bradley, C. Francisconi et al., Psychosocial aspects of the functional gastrointestinal disorders Syndrome de l'intestin irritable : diagnostic chez l'adulte Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. French Club of Digestive Motility Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness Symptomatology, quality of life and economic features of irritable bowel syndrome--the effect of hypnotherapy Hypnotherapy in severe irritable bowel syndrome: further experience Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome, The burden cost of French patients suffering from irritable bowel syndrome1447?1458. 11. Coffin BS9?S16. 12. Delvaux M954?961. 14):91?95. 15. Whorwell PJ,1232?1234. 17. Gonsalkorale WM, Miller V, Afzal A, Whorwell PJ. Long term benefits of hypnotherapy for irritable bowel syndrome, pp.345-352, 1984.

B. Bonaz, . Communication-entre-cerveau-et-intestin, R. La-revue-de-médecine-interne-lea, V. Hopkins, J. Hastleton et al., 581?585. 19 Diagnostic criteria for irritable bowel syndrome: utility and applicability in clinical practice Physician knowledge of Rome symptom criteria for irritable bowel syndrome is poor among non-gastroenterologists Le dysfonctionnement du « brain-gut » « Irritable bowel symptoms » in inflammatory bowel disease: diagnostic uncertainty meets pathological reality The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?, 210?213. 20. Charapata C, Mertz H, pp.614-620, 1985.

V. Plourde, . Stress, B. Bonaz, G. Bouguen, B. Sytnik et al., Corticotropin-releasing factor receptors and stress-related alterations of gut motor function Journal of Clinical Investigation. 2 janv Troubles de la motricité intestinale et hypersensibilité viscérale dans le syndrome de l'intestin irritable Corticotropin Releasing Factor (CRF) increases post-prandial duodenal motor activity in humans Basic and clinical aspects of visceral hyperalgesia, the gastrointestinal motor system, pp.53-60, 1992.

J. Thurin, N. Baumann, S. Coutinho, P. Plotsky, M. Sablad et al., Stress, Pathologies et Immunité Chapitre 17 Médecine Sciences Publications; 2003. 31 Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat):G307?316. 32. Spiller RC. Postinfectious irritable bowel syndrome Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls Psychological adjustment and autonomic disturbances in inflammatory bowel diseases and irritable bowel syndrome al. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome?, Gastroenterology. juill Am J Physiol Gastrointest Liver Physiol. févr Gastroenterology. mai Gut. nov Psychoneuroendocrinology. juin Am J Physiol Gastrointest Liver Physiol. juin, vol.1072821245335296, issue.331156, pp.653-662, 1994.

H. Lin, G. Barbara, H. Flint, B. Spiegel, R. Spiller et al., Small Intestinal Bacterial Overgrowth, JAMA, vol.292, issue.7, pp.159-176, 2004.
DOI : 10.1001/jama.292.7.852

H. Selye, M. Bruchon-schweitzer, and M. Bourgeois, Personnalité et maladies: stress, coping et ajustement. Dunod; 2001. 40. Chabrol H, Callahan S. Mécanismes de défense et coping. Dunod; 2004. 41. Lazarus RS, Folkman S. Stress, Appraisal, and Coping Bruchon-Schweitzer M. Concepts, stress, coping Stress et coping : un modèle intégratif en psychologie de la santé. Annales Médico-psychologiques, revue psychiatrique, 809?815. 44. Bruchon-Schweitzer M. Psychologie de la santé: Modèles, concepts et méthodes. Dunod, p.45, 1984.

D. Drossman, Review article: an integrated approach to the irritable bowel syndrome, Alimentary Pharmacology and Therapeutics, vol.44, issue.s2
DOI : 10.1016/0304-3959(90)91107-T

H. Mertz, Irritable bowel syndrome, N Engl J Med. 27 nov, vol.349, issue.22, pp.2136-2146, 2003.

P. Ducrotté, J. Rubenstein, P. Young, A. Gentry, B. Nojkov et al., The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls):1187?1193. 50. Ford AC, Moayyedi P. Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome The placebo effect in irritable bowel syndrome trials: a meta-analysis1, Presse Med. nov Gastroenterology. oct Alimentary Pharmacology & Therapeutics. Neurogastroenterology & Motility, vol.361413217, issue.11423, pp.144-58, 2005.

T. Poynard, C. Regimbeau, and Y. Benhamou, A randomized, double-blind, placebo-controlled study Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome, 355?361. 54. Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome, pp.1115-1123, 2001.

R. Udave, H. Maldonado-garza, and F. Bosques-padilla, Effect of antispasmodic agents, alone or in combination, in the treatment of Irritable Bowel Syndrome: Systematic review and metaanalysis, Rev Gastroenterol Mex. avr, vol.77, issue.2, pp.82-90, 2012.

P. Ducrotte, M. Dapoigny, B. Bonaz, L. Siproudhis, C. Frissora et al., Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome Alimentary Pharmacology & Therapeutics Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat, ):1271?81. 58541?551. 60. Mckernan DP al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors, pp.1029-268, 2005.

N. Talley, P. Schoenfeld, E. Quigley, and P. Moayyedi, The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis, Gut. 17 déc Gut. 10 nov, vol.5958, issue.33, pp.367-378, 2008.

J. Jackson, O. Malley, P. Tomkins, G. Balden, E. Santoro et al., Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis1 Psychological Treatments for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis The costeffectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: A double blind, randomized, placebo-controlled study, 65?72. 65. Lackner JM, pp.303-317, 2000.

M. Beaves, J. Wang, P. Friday, H. Mardini, and G. Arnold, Paroxetine to Treat Irritable Bowel Syndrome Not Responding to High-Fiber Diet: A Double-Blind, Placebo- Controlled Trial, Citalopram Provides Little or No Benefit in Nondepressed Patients With Irritable Bowel Syndrome42?48.e1. 69. Tabas G,):914?920. 70. Tack J. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut. 27 sept):1095?1103. 71, 2004.

H. Vahedi, S. Merat, A. Rashidioon, A. Ghoddoosi, R. Malekzadeh et al., Effect of a second-generation ?2? ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome Efficacy of 5-HT3 Antagonists and 5-HT4 Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. The American Journal of Gastroenterology Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial Hypnotherapy for treatment of irritable bowel syndrome Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome al. A Treatment Trial of Acupuncture in IBS Patients antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis Herbal remedies for dyspepsia: peppermint seems effective, 1218?1225. 73. Ford AC):1831?1843. 74. Prior A Disponible sur769?780. 78. Lembo AJ, pp.115-76, 1990.

J. Godin, La nouvelle hypnose: vocabulaire, principes et méthode : introduction à l'hypnothérapie éricksonienne, Editions Albin Michel, p.83, 1992.

M. Kerouac, M. La-faymonville, M. Boly, S. Laureys, G. Debenedittis et al., Autonomic Changes During Hypnosis: A Heart Rate Variability Power Spectrum Analysis as a Marker of Sympatho-Vagal Balance Treatment With Hypnotherapy Reduces the Sensory and Motor Component of the Gastrocolonic Response in Irritable Bowel Syndrome Analyse multidimensionnelle d'une échelle de coping : validation française de la W.C.C. (ways of coping checklist) Psychologie française Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire Understanding Gastrointestinal Distress: A Framework for Clinical Practice [First validation of the French version of the Gastrointestinal Quality of Life Index (GIQLI)] Description et traduction de l'échelle d'autoévaluation A Global Measure of Perceived Stress, Métaphore thérapeutique et ses contes: études éricksoniennes. MKR éditions Functional neuroanatomy of the hypnotic state140?152. 86. Simrén M):233?238. 87. Cousson F380?385. 90. Slim25?31. 91 Sexual and Physical Abuse and Gastrointestinal Illness: Review and Recommendations782?794. 92. Fuhrer, R.; Rouillon, F. La version française de l'échelle CES-D (Center for Epidemiologic Studies-Depression Scale) The French version of the CES-D (Center for Epidemiologic Studies- Depression Scale). 1989. p. 163?166. 93. Spielberger CD, Bruchon-Schweitzer M, Paulhan I. Inventaire d'anxiété état-trait forme Y (STAI-Y), pp.4-6, 1983.

B. Quintard, M. Du-stress-objectif-au-stress-perçu.-de-bruchon-schweitzer, and R. Dantzer, Introduction à la psychologie de la santé. Collection psychologie d'aujourd'hui. Paris. PUF; 1994, 43?66. 96. Longstreth GF, Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees

D. Drossman, J. Leserman, G. Nachman, Z. Li, H. Gluck et al., Sexual and physical abuse in women with functional or organic gastrointestinal disorders Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials, 276?285. 99. Lowén MBO, pp.1184-97, 1990.

C. Flik, Y. Van-rood, W. Laan, A. Smout, B. Weusten et al., A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study), BMC Gastroenterology, vol.32, issue.2, p.137, 2011.
DOI : 10.1111/j.1365-2036.2010.04328.x